The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Novartis AG

NYSE: NVS
Last

(U.S.) $94.61

Today's change+0.04 +0.04%
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.
 

Novartis AG

NYSE: NVS
Last

(U.S.) $94.61

Today's change+0.04 +0.04%
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.

Novartis AG up slightly

Novartis AG closed up just (U.S.)$0.04 Friday to (U.S.)$94.61. Over the last five days, shares have gained 1.17% and are currently 2.43% off of the 52-week high. Shares have outperformed the S&P 500 by 5.99% during the last year.

Key company metrics

  • Open(U.S.) $94.41
  • Previous close(U.S.) $94.57
  • High(U.S.) $95.00
  • Low(U.S.) $94.00
  • Bid / Ask-- / --
  • YTD % change+17.70%
  • Volume1,593,022
  • Average volume (10-day)1,368,401
  • Average volume (1-month)1,277,222
  • Average volume (3-month)1,353,964
  • 52-week range(U.S.) $77.90 to (U.S.) $96.97
  • Beta0.50
  • Trailing P/E22.80×
  • P/E 1 year forward18.05×
  • Forward PEG2.05×
  • Indicated annual dividend(U.S.) $2.76
  • Dividend yield2.92%
  • Trailing EPS(U.S.) $4.15
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.58%

Based on its net profit margin of 18.58%, Novartis AG is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue13,30013,94913,03115,363
Total other revenue--------
Total revenue13,30013,94913,03115,363
Gross profit8,8799,5718,90110,051
Total cost of revenue4,4214,3784,1305,312
Total operating expense10,56110,76510,21612,990
Selling / general / administrative3,5653,8263,6374,776
Research & development2,1612,1782,2102,697
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total414383239205
Operating income2,7393,1842,8152,373
Interest income (expense), net non-operating-182-166-168-163
Gain (loss) on sale of assets--------
Other--------
Income before tax3,5323,1472,8372,322
Income after tax3,1022,7232,4542,058
Income tax, total430424383264
Net income3,2232,5552,9412,029
Total adjustments to net income--------
Net income before extra. items3,0852,6932,4272,029
Minority interest-17-30-27-29
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,0852,6932,4272,029
Inc. avail. to common incl. extra. items3,2232,5552,9412,029
Diluted net income3,2232,5552,9412,029
Dilution adjustment000--
Diluted weighted average shares2,4602,4712,4742,473
Diluted EPS excluding extraordinary itemsvalue per share1.251.090.980.82
Dividends per sharevalue per share0.000.000.002.43
Diluted normalized EPSvalue per share1.361.320.850.92